Home » Provectus Receives Indian Patent for Cancer Drug
Provectus Receives Indian Patent for Cancer Drug
December 13, 2007
Tennessee-based Provectus Pharmaceuticals has received a patent in India for its cancer drug PV-10.
The patent covers capsules, tablets, injectable formulations and oral suspensions and solutions, Provectus said.
The company is conducting Phase II trials on PV-10 as a treatment for melanoma and breast cancer.
Upcoming Events
-
21Oct